173 results on '"Imai, Kentaro"'
Search Results
2. WCN24-1446 The Role of Long Non-Coding RNAs in the Progression of Renal Fibrosis
3. ADJUVANT PEMBROLIZUMAB FOR RENAL CELL CARCINOMA (KEYNOTE-564): EXPLORATORY ANALYSIS ACROSS UCLA INTEGRATED STAGING SYSTEM RISK GROUPS AND DISEASE STAGE
4. Campylobacter jejuni 腸炎を契機に発症したメトホルミン関連乳酸アシドーシスに対し，長時間の血液透析を施行し救命した1例
5. Coastal tsunami prediction in Tohoku region, Japan, based on S-net observations using artificial neural network
6. Temporal changes in treatment patterns by age group and functional status before and after PD-1/L1 inhibitor approvals in advanced urothelial carcinoma
7. Cost-Effectiveness Analysis of Pembrolizumab as an Adjuvant Treatment of Renal Cell Carcinoma Post-nephrectomy in the United States
8. A Study of Depth of Cut and Wear in Precision Grinding of CVD-SiC
9. Effects of Temperature and Relative Humidity on Crack Propagation Behavior During Wheel Scribing of Alkali-Free Glass Sheet
10. Surgical technique for preventing lung torsion after right upper and lower bilobectomy
11. Uptake of Maintenance Immunotherapy and Changes in Upstream Treatment Selection Among Patients With Urothelial Cancer
12. MP19-15 EXPLORING PERCEPTIONS OF THE RISK OF RECURRENCE IN RENAL CELL CARCINOMA: EVIDENCE FROM A SURVEY OF PRACTICING PHYSICIANS
13. Real-time tsunami damage prediction using DONET and the implementation
14. Long non-coding RNA lnc-CHAF1B-3 promotes renal interstitial fibrosis by regulating EMT-related genes in renal proximal tubular cells
15. Uptake of maintenance immunotherapy and changes in upstream treatment selection in patients with advanced urothelial cancer (aUC).
16. Adjuvant pembrolizumab (pembro) for renal cell carcinoma (RCC) across UCLA Integrated Staging System (UISS) risk groups and disease stage: Subgroup analyses from the KEYNOTE-564 study.
17. Heterogeneity in physician and patient preferences for the treatment of renal cell carcinoma: Evidence from latent class analysis.
18. Patient and physician preferences for adjuvant treatment of renal cell carcinoma: A discrete-choice experiment.
19. Data Assimilation Using High‐Frequency Radar for Tsunami Early Warning: A Case Study of the 2022 Tonga Volcanic Tsunami
20. Consideration of Bending Behavior of Sheet Steel in Roller Hemming
21. 沖合観測網と津波干渉法を利用したリアルタイム津波予測の可能性
22. Pembrolizumab versus placebo as post-nephrectomy adjuvant therapy for clear cell renal cell carcinoma (KEYNOTE-564): 30-month follow-up analysis of a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial
23. Impact of Label Restriction on Checkpoint-Inhibitor Use in Bladder Cancer and Changes in Mortality
24. Source Reconstruction of the 1969 Western Sulawesi, Indonesia, Earthquake and Tsunami
25. Tsunami Early Warning of the Hunga Volcanic Eruption Using an Ocean Floor Observation Network Off the Japanese Islands
26. Disease-free and overall survival outcomes for localized RCC patients by disease stage.
27. Adjuvant pembrolizumab for postnephrectomy renal cell carcinoma (RCC): Expanded efficacy analyses from KEYNOTE-564.
28. Health-related quality of life (HRQoL) for patients with advanced/metastatic urothelial carcinoma (UC) enrolled in KEYNOTE-052 who are potentially platinum ineligible.
29. Adjuvant Chemotherapy for High-risk Pathologic Stage I Non-Small Cell Lung Cancer
30. Two cases of ceftriaxone‐induced encephalopathy treated by hemoperfusion in hemodialysis patients
31. Impact of primary tumor location on efficacy and safety of pembrolizumab (pembro) in patients (pts) with locally advanced or metastatic urothelial carcinoma (UC) enrolled in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-045 trials.
32. Pembrolizumab as post nephrectomy adjuvant therapy for patients with renal cell carcinoma: Results from 30-month follow-up of KEYNOTE-564.
33. First-line pembrolizumab in advanced urothelial carcinoma: Clinical parameters associated with efficacy in the phase 2 KEYNOTE-052 and phase 3 KEYNOTE-361 trials.
34. Post hoc pooled analysis of first-line (1L) pembrolizumab (pembro) for advanced urothelial carcinoma (UC): Outcomes by response at week nine in KEYNOTE-052 and KEYNOTE-361.
35. Association of TMB and PD-L1 with efficacy of first-line pembrolizumab (pembro) or pembro + chemotherapy (chemo) versus chemo in patients (pts) with advanced urothelial carcinoma (UC) from KEYNOTE-361.
36. Impact of FDA label change on immunotherapy for metastatic urothelial cancer (mUC) and subsequent changes in mortality.
37. Post hoc analysis of the efficacy of pembrolizumab retreatment after progression of advanced urothelial carcinoma (UC) in KEYNOTE-045 and KEYNOTE-052.
38. Realtime Tsunami Prediction System Using Ocean Floor Network for Local Regions
39. Development of a Practical Evaluation Method for Tsunami Debris and Its Accumulation
40. Time difference between the 1854 CE Ansei–Tokai and Ansei–Nankai earthquakes estimated from distant tsunami waveforms on the west coast of North America
41. Pathological Findings after Transbronchial PDT for the Peripheral Lung
42. Variation analysis of multiple tsunami inundation models
43. Corrigendum to “Modeling of a dispersive tsunami caused by a submarine landslide based on detailed bathymetry of the continental slope in the Nankai trough, southwest Japan” [Tectonophysics 768 (2019) 228182]
44. Effect of photodynamic therapy (PDT) on a rat model of bleomycin-induced interstitial pneumonia
45. Frequency dispersion amplifies tsunamis caused by outer-rise normal faults
46. Time Difference Between the 1854 CE Ansei–Tokai and Ansei–Nankai Earthquakes Estimated from Distant Tsunami Waveforms on the West Coast of North America
47. PLLBA-01 PEMBROLIZUMAB (PEMBRO) VS PLACEBO AS POST NEPHRECTOMY ADJUVANT THERAPY FOR PATIENTS (pts) WITH RENAL CELL CARCINOMA (RCC): RANDOMIZED, DOUBLE-BLIND, PHASE 3 KEYNOTE-564 STUDY
48. Adjuvant Pembrolizumab after Nephrectomy in Renal-Cell Carcinoma
49. A Method to Determine the Level 1 and Level 2 Tsunami Inundation Areas for Reconstruction in Eastern Japan and Possible Application in Pre-disaster Areas
50. Risk of death due to other causes is lower among octogenarians with non-small cell lung cancer after wedge resection than lobectomy/segmentectomy
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.